Global Endocrine Testing Market Forecast 2035
According to the report, the global endocrine testing market is likely to grow from USD 11.5 Billion in 2025 to USD 22.3 Billion in 2035 at a highest CAGR of 6.2% during the time period. The endocrine testing market is recording a tremendous growth due to the rising prevalence of endocrine diseases like diabetes, thyroid dysfunctions, and hormonal imbalances in the developed and emerging economies. The increased sensitivity to early diagnosis and preventive healthcare has increased the need to obtain accurate and timely endocrine tests. Immunoassays, biosensors, and high-throughput testing platforms are all improving technological advances that are allowing quantification of hormones faster and more accurately that is helping in clinical decisions. Besides, market expansion is further driven by the increasing geriatric population that is more prone to endocrine disorders. The growing investments in healthcare infrastructure and the automation of laboratories, especially in North America, Europe and the Asia Pacific, are making endocrine testing easier to reach. In addition, government programs that encourage regular screenings of their health and programs of managing chronic diseases have been driving its adoption within hospitals, diagnostic centers and research laboratories. The continued development of the global endocrine testing market is also due to strategic partnerships between diagnostic businesses and introduction of new test kits.
“Key Driver, Restraint, and Growth Opportunity Shaping the Global Endocrine Testing Market
The major limitations are the expensive nature and complexity of state-of-the-art endocrine testing devices and tests, which may restrict their use in smaller clinics and other low-resource areas. The shortage of trained staff to use advanced diagnostic platforms is also a problem to a large-scale implementation.
An opportunity is seen in the growth of point-of- care endocrine testing devices. Mobile and quick hormone test kits enable real-time testing of patients in an outpatient clinic, distant clinics, and even home-based health care offering convenience and a quicker clinical decision-making process, especially in areas with a sparse lab infrastructure.
Expansion of Global Endocrine Testing Market
“Global Endocrine Testing Market Expansion Driven by Chronic Disease Prevalence, Technological Advancements, and Healthcare Accessibility”
- The global endocrine testing market is growing because of increasing cases of chronic endocrine diseases like diabetes, obesity and thyroid disorders. The International Diabetes Federation indicates that by the year 2040, more than 640 million adults will have diabetes and this is the reason why endocrine monitoring should be routinely done. Rise in cases of hormonal imbalances in the aging societies further stimulate the result in need of specific and accurate testing solutions within the hospitals, diagnostic centers and research centers.
- The other major catalyst to market growth is that there are technological developments. Immunoassays, high-sensitivity ELISA kits as well as automated testing platforms are innovating, faster and more accurate measurements of the hormones. As an illustration, Roche Diagnostics and Abbott Laboratories have come up with high-endocrine testing electrophoresis able to conduct high throughput testing, hence lowering turnaround time and enhancing clinical efficacy.
- Accessibility of healthcare is also improved and government programs facilitate market growth. The use of endocrine testing is growing as a result of programs encouraging the regular check-ups and preventive measures in nations such as India, China, and the U.S. Moreover, the invention of portable and point-of-care testing system allows the monitoring of the hormones in the remote locations, increasing the range and usage, especially in the newer market.
Regional Analysis of Global Endocrine Testing Market
- Endocrine testing is most needed in North America because of the prevalence of endocrine and metabolic diseases that include diabetes, obesity and thyroid diseases. Centers of disease control and prevention (CDC) report that more than 37 million Americans are already living with diabetes and millions more have thyroid and hormonal imbalances, leading to the routine testing and monitoring of hormones. Also, the region has developed healthcare facilities, and excellent access to diagnostic laboratories, and knowledge about preventive care, which results in the massive use of the endocrine testing services in hospitals, clinics, and research institutions. Market penetration is also enhanced by the presence of major diagnostic firms in the market such as Abbott Laboratories, Roche Diagnostics and Siemens Healthineers.
- Asia Pacific will see the greatest expansion in the market of endocrine testing owing to the rapid urbanization, rising disposable income and the growing awareness of preventive healthcare. Flattened countries like China, India, and Japan are on an upsurge of these lifestyle related diseases like diabetes and obesity and as such, demand of routine hormone testing is increasing. The growth of the healthcare industry is being accelerated by government interventions designed to enhance access to healthcare, along with the growth of diagnostics infrastructure and the implementation of point-of-care testing equipment. As an example, telemedicine software and mobile diagnostic clinics in India are enabling endocrine testing in distant areas, which is generating new development opportunities in the region.
Prominent players operating in the global endocrine testing market are Abbott Laboratories, Beckman Coulter (Danaher), BioMérieux, Bio-Rad Laboratories, Bio-Techne Corporation, DiaSorin, EUROIMMUN AG, IDS (Immunodiagnostic Systems), Luminex Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PerkinElmer, Promega Corporation, Quidel Corporation, Roche Diagnostics, Siemens Healthineers, Sigma-Aldrich (Merck Group), Thermo Fisher Scientific, Tosoh Bioscience, Trinity Biotech, and Other Key Players.
The global endocrine testing market has been segmented as follows:
Global Endocrine Testing Market Analysis, by Test Type
- Thyroid Function Tests (T3, T4, TSH)
- Adrenal Function Tests (Cortisol, ACTH)
- Reproductive Hormone Tests (Estrogen, Progesterone, Testosterone, LH, FSH)
- Glucose-related Tests (Insulin, C-peptide)
- Calcium & Parathyroid Tests (PTH, Calcium levels)
- Others
Global Endocrine Testing Market Analysis, by Technology Platform
- Immunoassays (e.g., ELISA, CLIA)
- Mass Spectrometry (e.g., LC-MS/MS)
- Radioimmunoassays (RIA)
- Chromatography-based Techniques
- Point-of-Care Testing Devices
- Others
Global Endocrine Testing Market Analysis, by Sample Type
- Serum/ Plasma
- Urine
- Saliva
- Blood (Whole Blood Fingerstick)
- Others
Global Endocrine Testing Market Analysis, by Mode of Testing
- Automated High-throughput Testing
- Manual/ Manual Batch Testing
- Semi-automated Testing
Global Endocrine Testing Market Analysis, by Pricing Tier
- Basic Panels
- Advanced Multiplex Panels
- Customized Hormone Profiling Packages
- Others
Global Endocrine Testing Market Analysis, by Indication/ Application
- Diagnostic Screening (e.g., thyroid dysfunction)
- Disease Monitoring (e.g., diabetes, adrenal disorders)
- Fertility & Reproductive Health
- Growth & Development Assessments
- Clinical Research & Drug Development
- Others
Global Endocrine Testing Market Analysis, by End Users
- Hospital Laboratories
- Diagnostic and Reference Labs
- Point-of-Care Clinics
- Research Institutes
- Home Testing Kits
- Others
Global Endocrine Testing Market Analysis, by Region
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact Us
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global Endocrine Testing Market Outlook
- 2.1.1. Endocrine Testing Market Size (Value - US$ Billion), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End Use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global Endocrine Testing Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Overview, 2025
- 3.1.1. Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising prevalence of endocrine disorders including diabetes and thyroid dysfunction, especially amid aging and sedentary lifestyles.
- 4.1.1.2. Advancements in diagnostic technologies such as high‑sensitivity immunoassays and LC‑MS/MS enhancing accuracy and efficiency.
- 4.1.1.3. Growing awareness and emphasis on preventive healthcare boosting routine screening and point‑of‑care testing.
- 4.1.2. Restraints
- 4.1.2.1. High costs associated with advanced testing equipment, assays, and R&D hinder access, especially in developing regions
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis/ Ecosystem Analysis
- 4.4.1. Raw Material/ Reagent Suppliers
- 4.4.2. Diagnostic Equipment & Assay Manufacturers
- 4.4.3. Distributors & Diagnostic Labs
- 4.4.4. End Users
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Porter’s Five Forces Analysis
- 4.7. PESTEL Analysis
- 4.8. Global Endocrine Testing Market Demand
- 4.8.1. Historical Market Size - in Value (Value - US$ Billion), 2021-2024
- 4.8.2. Current and Future Market Size - in Value (Value - US$ Billion), 2025–2035
- 4.8.2.1. Y-o-Y Growth Trends
- 4.8.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global Endocrine Testing Market Analysis, by Test Type
- 6.1. Key Segment Analysis
- 6.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Test Type, 2021-2035
- 6.2.1. Thyroid Function Tests (T3, T4, TSH)
- 6.2.2. Adrenal Function Tests (Cortisol, ACTH)
- 6.2.3. Reproductive Hormone Tests (Estrogen, Progesterone, Testosterone, LH, FSH)
- 6.2.4. Glucose-related Tests (Insulin, C-peptide)
- 6.2.5. Calcium & Parathyroid Tests (PTH, Calcium levels)
- 6.2.6. Others
- 7. Global Endocrine Testing Market Analysis, by Mounting Type
- 7.1. Key Segment Analysis
- 7.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Mounting Type, 2021-2035
- 7.2.1. Immunoassays (e.g., ELISA, CLIA)
- 7.2.2. Mass Spectrometry (e.g., LC-MS/MS)
- 7.2.3. Radioimmunoassays (RIA)
- 7.2.4. Chromatography-based Techniques
- 7.2.5. Point-of-Care Testing Devices
- 7.2.6. Others
- 8. Global Endocrine Testing Market Analysis, by Sample Type
- 8.1. Key Segment Analysis
- 8.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Sample Type, 2021-2035
- 8.2.1. Serum/ Plasma
- 8.2.2. Urine
- 8.2.3. Saliva
- 8.2.4. Blood (Whole Blood Fingerstick)
- 8.2.5. Others
- 9. Global Endocrine Testing Market Analysis, by Mode of Testing
- 9.1. Key Segment Analysis
- 9.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Mode of Testing, 2021-2035
- 9.2.1. Automated High-throughput Testing
- 9.2.2. Manual/ Manual Batch Testing
- 9.2.3. Semi-automated Testing
- 10. Global Endocrine Testing Market Analysis, by Pricing Tier
- 10.1. Key Segment Analysis
- 10.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Pricing Tier, 2021-2035
- 10.2.1. Basic Panels
- 10.2.2. Advanced Multiplex Panels
- 10.2.3. Customized Hormone Profiling Packages
- 10.2.4. Others
- 11. Global Endocrine Testing Market Analysis, by Indication/ Application
- 11.1. Key Segment Analysis
- 11.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Indication/ Application, 2021-2035
- 11.2.1. Diagnostic Screening (e.g., thyroid dysfunction)
- 11.2.2. Disease Monitoring (e.g., diabetes, adrenal disorders)
- 11.2.3. Fertility & Reproductive Health
- 11.2.4. Growth & Development Assessments
- 11.2.5. Clinical Research & Drug Development
- 11.2.6. Others
- 12. Global Endocrine Testing Market Analysis, by End-User Setting
- 12.1. Key Segment Analysis
- 12.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by End-User Setting, 2021-2035
- 12.2.1. Hospital Laboratories
- 12.2.2. Diagnostic and Reference Labs
- 12.2.3. Point-of-Care Clinics
- 12.2.4. Research Institutes
- 12.2.5. Home Testing Kits
- 12.2.6. Others
- 13. Global Endocrine Testing Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- 14. North America Endocrine Testing Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America Endocrine Testing Market Size Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 14.3.1. Test Type
- 14.3.2. Mounting Type
- 14.3.3. Sample Type
- 14.3.4. Mode of Testing
- 14.3.5. Pricing Tier
- 14.3.6. Indication/ Application
- 14.3.7. End-User Setting
- 14.3.8. Country
- 14.3.8.1. USA
- 14.3.8.2. Canada
- 14.3.8.3. Mexico
- 14.4. USA Endocrine Testing Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Test Type
- 14.4.3. Mounting Type
- 14.4.4. Sample Type
- 14.4.5. Mode of Testing
- 14.4.6. Pricing Tier
- 14.4.7. Indication/ Application
- 14.4.8. End-User Setting
- 14.5. Canada Endocrine Testing Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Test Type
- 14.5.3. Mounting Type
- 14.5.4. Sample Type
- 14.5.5. Mode of Testing
- 14.5.6. Pricing Tier
- 14.5.7. Indication/ Application
- 14.5.8. End-User Setting
- 14.6. Mexico Endocrine Testing Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Test Type
- 14.6.3. Mounting Type
- 14.6.4. Sample Type
- 14.6.5. Mode of Testing
- 14.6.6. Pricing Tier
- 14.6.7. Indication/ Application
- 14.6.8. End-User Setting
- 15. Europe Endocrine Testing Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 15.3.1. Test Type
- 15.3.2. Mounting Type
- 15.3.3. Sample Type
- 15.3.4. Mode of Testing
- 15.3.5. Pricing Tier
- 15.3.6. Indication/ Application
- 15.3.7. End-User Setting
- 15.3.8. Country
- 15.3.8.1. Germany
- 15.3.8.2. United Kingdom
- 15.3.8.3. France
- 15.3.8.4. Italy
- 15.3.8.5. Spain
- 15.3.8.6. Netherlands
- 15.3.8.7. Nordic Countries
- 15.3.8.8. Poland
- 15.3.8.9. Russia & CIS
- 15.3.8.10. Rest of Europe
- 15.4. Germany Endocrine Testing Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Test Type
- 15.4.3. Mounting Type
- 15.4.4. Sample Type
- 15.4.5. Mode of Testing
- 15.4.6. Pricing Tier
- 15.4.7. Indication/ Application
- 15.4.8. End-User Setting
- 15.5. United Kingdom Endocrine Testing Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Test Type
- 15.5.3. Mounting Type
- 15.5.4. Sample Type
- 15.5.5. Mode of Testing
- 15.5.6. Pricing Tier
- 15.5.7. Indication/ Application
- 15.5.8. End-User Setting
- 15.6. France Endocrine Testing Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Test Type
- 15.6.3. Mounting Type
- 15.6.4. Sample Type
- 15.6.5. Mode of Testing
- 15.6.6. Pricing Tier
- 15.6.7. Indication/ Application
- 15.6.8. End-User Setting
- 15.7. Italy Endocrine Testing Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Test Type
- 15.7.3. Mounting Type
- 15.7.4. Sample Type
- 15.7.5. Mode of Testing
- 15.7.6. Pricing Tier
- 15.7.7. Indication/ Application
- 15.7.8. End-User Setting
- 15.8. Spain Endocrine Testing Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Test Type
- 15.8.3. Mounting Type
- 15.8.4. Sample Type
- 15.8.5. Mode of Testing
- 15.8.6. Pricing Tier
- 15.8.7. Indication/ Application
- 15.8.8. End-User Setting
- 15.9. Netherlands Endocrine Testing Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Test Type
- 15.9.3. Mounting Type
- 15.9.4. Sample Type
- 15.9.5. Mode of Testing
- 15.9.6. Pricing Tier
- 15.9.7. Indication/ Application
- 15.9.8. End-User Setting
- 15.10. Nordic Countries Endocrine Testing Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Test Type
- 15.10.3. Mounting Type
- 15.10.4. Sample Type
- 15.10.5. Mode of Testing
- 15.10.6. Pricing Tier
- 15.10.7. Indication/ Application
- 15.10.8. End-User Setting
- 15.11. Poland Endocrine Testing Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Test Type
- 15.11.3. Mounting Type
- 15.11.4. Sample Type
- 15.11.5. Mode of Testing
- 15.11.6. Pricing Tier
- 15.11.7. Indication/ Application
- 15.11.8. End-User Setting
- 15.12. Russia & CIS Endocrine Testing Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Test Type
- 15.12.3. Mounting Type
- 15.12.4. Sample Type
- 15.12.5. Mode of Testing
- 15.12.6. Pricing Tier
- 15.12.7. Indication/ Application
- 15.12.8. End-User Setting
- 15.13. Rest of Europe Endocrine Testing Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Test Type
- 15.13.3. Mounting Type
- 15.13.4. Sample Type
- 15.13.5. Mode of Testing
- 15.13.6. Pricing Tier
- 15.13.7. Indication/ Application
- 15.13.8. End-User Setting
- 16. Asia Pacific Endocrine Testing Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. East Asia Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 16.3.1. Test Type
- 16.3.2. Mounting Type
- 16.3.3. Sample Type
- 16.3.4. Mode of Testing
- 16.3.5. Pricing Tier
- 16.3.6. Indication/ Application
- 16.3.7. End-User Setting
- 16.3.8. Country
- 16.3.8.1. China
- 16.3.8.2. India
- 16.3.8.3. Japan
- 16.3.8.4. South Korea
- 16.3.8.5. Australia and New Zealand
- 16.3.8.6. Indonesia
- 16.3.8.7. Malaysia
- 16.3.8.8. Thailand
- 16.3.8.9. Vietnam
- 16.3.8.10. Rest of Asia Pacific
- 16.4. China Endocrine Testing Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Test Type
- 16.4.3. Mounting Type
- 16.4.4. Sample Type
- 16.4.5. Mode of Testing
- 16.4.6. Pricing Tier
- 16.4.7. Indication/ Application
- 16.4.8. End-User Setting
- 16.5. India Endocrine Testing Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Test Type
- 16.5.3. Mounting Type
- 16.5.4. Sample Type
- 16.5.5. Mode of Testing
- 16.5.6. Pricing Tier
- 16.5.7. Indication/ Application
- 16.5.8. End-User Setting
- 16.6. Japan Endocrine Testing Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Test Type
- 16.6.3. Mounting Type
- 16.6.4. Sample Type
- 16.6.5. Mode of Testing
- 16.6.6. Pricing Tier
- 16.6.7. Indication/ Application
- 16.6.8. End-User Setting
- 16.7. South Korea Endocrine Testing Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Test Type
- 16.7.3. Mounting Type
- 16.7.4. Sample Type
- 16.7.5. Mode of Testing
- 16.7.6. Pricing Tier
- 16.7.7. Indication/ Application
- 16.7.8. End-User Setting
- 16.8. Australia and New Zealand Endocrine Testing Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Test Type
- 16.8.3. Mounting Type
- 16.8.4. Sample Type
- 16.8.5. Mode of Testing
- 16.8.6. Pricing Tier
- 16.8.7. Indication/ Application
- 16.8.8. End-User Setting
- 16.9. Indonesia Endocrine Testing Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Test Type
- 16.9.3. Mounting Type
- 16.9.4. Sample Type
- 16.9.5. Mode of Testing
- 16.9.6. Pricing Tier
- 16.9.7. Indication/ Application
- 16.9.8. End-User Setting
- 16.10. Malaysia Endocrine Testing Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Test Type
- 16.10.3. Mounting Type
- 16.10.4. Sample Type
- 16.10.5. Mode of Testing
- 16.10.6. Pricing Tier
- 16.10.7. Indication/ Application
- 16.10.8. End-User Setting
- 16.11. Thailand Endocrine Testing Market
- 16.11.1. Country Segmental Analysis
- 16.11.2. Test Type
- 16.11.3. Mounting Type
- 16.11.4. Sample Type
- 16.11.5. Mode of Testing
- 16.11.6. Pricing Tier
- 16.11.7. Indication/ Application
- 16.11.8. End-User Setting
- 16.12. Vietnam Endocrine Testing Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Test Type
- 16.12.3. Mounting Type
- 16.12.4. Sample Type
- 16.12.5. Mode of Testing
- 16.12.6. Pricing Tier
- 16.12.7. Indication/ Application
- 16.12.8. End-User Setting
- 16.13. Rest of Asia Pacific Endocrine Testing Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Test Type
- 16.13.3. Mounting Type
- 16.13.4. Sample Type
- 16.13.5. Mode of Testing
- 16.13.6. Pricing Tier
- 16.13.7. Indication/ Application
- 16.13.8. End-User Setting
- 17. Middle East Endocrine Testing Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 17.3.1. Test Type
- 17.3.2. Mounting Type
- 17.3.3. Sample Type
- 17.3.4. Mode of Testing
- 17.3.5. Pricing Tier
- 17.3.6. Indication/ Application
- 17.3.7. End-User Setting
- 17.3.8. Country
- 17.3.8.1. Turkey
- 17.3.8.2. UAE
- 17.3.8.3. Saudi Arabia
- 17.3.8.4. Israel
- 17.3.8.5. Rest of Middle East
- 17.4. Turkey Endocrine Testing Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Test Type
- 17.4.3. Mounting Type
- 17.4.4. Sample Type
- 17.4.5. Mode of Testing
- 17.4.6. Pricing Tier
- 17.4.7. Indication/ Application
- 17.4.8. End-User Setting
- 17.5. UAE Endocrine Testing Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Test Type
- 17.5.3. Mounting Type
- 17.5.4. Sample Type
- 17.5.5. Mode of Testing
- 17.5.6. Pricing Tier
- 17.5.7. Indication/ Application
- 17.5.8. End-User Setting
- 17.6. Saudi Arabia Endocrine Testing Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Test Type
- 17.6.3. Mounting Type
- 17.6.4. Sample Type
- 17.6.5. Mode of Testing
- 17.6.6. Pricing Tier
- 17.6.7. Indication/ Application
- 17.6.8. End-User Setting
- 17.7. Israel Endocrine Testing Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Test Type
- 17.7.3. Mounting Type
- 17.7.4. Sample Type
- 17.7.5. Mode of Testing
- 17.7.6. Pricing Tier
- 17.7.7. Indication/ Application
- 17.7.8. End-User Setting
- 17.8. Rest of Middle East Endocrine Testing Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Test Type
- 17.8.3. Mounting Type
- 17.8.4. Sample Type
- 17.8.5. Mode of Testing
- 17.8.6. Pricing Tier
- 17.8.7. Indication/ Application
- 17.8.8. End-User Setting
- 18. Africa Endocrine Testing Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 18.3.1. Test Type
- 18.3.2. Mounting Type
- 18.3.3. Sample Type
- 18.3.4. Mode of Testing
- 18.3.5. Pricing Tier
- 18.3.6. Indication/ Application
- 18.3.7. End-User Setting
- 18.3.8. Country
- 18.3.8.1. South Africa
- 18.3.8.2. Egypt
- 18.3.8.3. Nigeria
- 18.3.8.4. Algeria
- 18.3.8.5. Rest of Africa
- 18.4. South Africa Endocrine Testing Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Test Type
- 18.4.3. Mounting Type
- 18.4.4. Sample Type
- 18.4.5. Mode of Testing
- 18.4.6. Pricing Tier
- 18.4.7. Indication/ Application
- 18.4.8. End-User Setting
- 18.5. Egypt Endocrine Testing Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Test Type
- 18.5.3. Mounting Type
- 18.5.4. Sample Type
- 18.5.5. Mode of Testing
- 18.5.6. Pricing Tier
- 18.5.7. Indication/ Application
- 18.5.8. End-User Setting
- 18.6. Nigeria Endocrine Testing Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Test Type
- 18.6.3. Mounting Type
- 18.6.4. Sample Type
- 18.6.5. Mode of Testing
- 18.6.6. Pricing Tier
- 18.6.7. Indication/ Application
- 18.6.8. End-User Setting
- 18.7. Algeria Endocrine Testing Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Test Type
- 18.7.3. Mounting Type
- 18.7.4. Sample Type
- 18.7.5. Mode of Testing
- 18.7.6. Pricing Tier
- 18.7.7. Indication/ Application
- 18.7.8. End-User Setting
- 18.8. Rest of Africa Endocrine Testing Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Test Type
- 18.8.3. Mounting Type
- 18.8.4. Sample Type
- 18.8.5. Mode of Testing
- 18.8.6. Pricing Tier
- 18.8.7. Indication/ Application
- 18.8.8. End-User Setting
- 19. South America Endocrine Testing Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Central and South Africa Endocrine Testing Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 19.3.1. Test Type
- 19.3.2. Mounting Type
- 19.3.3. Sample Type
- 19.3.4. Mode of Testing
- 19.3.5. Pricing Tier
- 19.3.6. Indication/ Application
- 19.3.7. End-User Setting
- 19.3.8. Country
- 19.3.8.1. Brazil
- 19.3.8.2. Argentina
- 19.3.8.3. Rest of South America
- 19.4. Brazil Endocrine Testing Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Test Type
- 19.4.3. Mounting Type
- 19.4.4. Sample Type
- 19.4.5. Mode of Testing
- 19.4.6. Pricing Tier
- 19.4.7. Indication/ Application
- 19.4.8. End-User Setting
- 19.5. Argentina Endocrine Testing Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Test Type
- 19.5.3. Mounting Type
- 19.5.4. Sample Type
- 19.5.5. Mode of Testing
- 19.5.6. Pricing Tier
- 19.5.7. Indication/ Application
- 19.5.8. End-User Setting
- 19.6. Rest of South America Endocrine Testing Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Test Type
- 19.6.3. Mounting Type
- 19.6.4. Sample Type
- 19.6.5. Mode of Testing
- 19.6.6. Pricing Tier
- 19.6.7. Indication/ Application
- 19.6.8. End-User Setting
- 20. Key Players/ Company Profile
- 20.1. Abbott Laboratories
- 20.1.1. Company Details/ Overview
- 20.1.2. Company Financials
- 20.1.3. Key Customers and Competitors
- 20.1.4. Business/ Industry Portfolio
- 20.1.5. Product Portfolio/ Specification Details
- 20.1.6. Pricing Data
- 20.1.7. Strategic Overview
- 20.1.8. Recent Developments
- 20.2. Beckman Coulter (Danaher)
- 20.3. BioMerieux
- 20.4. Bio-Rad Laboratories
- 20.5. Bio-Techne Corporation
- 20.6. DiaSorin
- 20.7. EUROIMMUN AG
- 20.8. IDS (Immunodiagnostic Systems)
- 20.9. Luminex Corporation
- 20.10. Nova Biomedical
- 20.11. Ortho Clinical Diagnostics
- 20.12. PerkinElmer
- 20.13. Promega Corporation
- 20.14. Quidel Corporation
- 20.15. Roche Diagnostics
- 20.16. Siemens Healthineers
- 20.17. Sigma-Aldrich (Merck Group)
- 20.18. Thermo Fisher Scientific
- 20.19. Tosoh Bioscience
- 20.20. Trinity Biotech
- 20.21. Other Key Players
- 20.1. Abbott Laboratories
Note* - This is just tentative list of players. While providing the report, we will cover a greater number of players based on their revenue and share for each geography
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase and Others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players product portfolio
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources includes primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
